Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2003 1
2007 1
2008 2
2009 1
2010 2
2011 3
2012 4
2013 1
2014 2
2016 2
2017 1
2018 2
2019 1
2020 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Spinal stimulation for movement disorders.
Thiriez C, Gurruchaga JM, Goujon C, Fénelon G, Palfi S. Thiriez C, et al. Among authors: gurruchaga jm. Neurotherapeutics. 2014 Jul;11(3):543-52. doi: 10.1007/s13311-014-0291-0. Neurotherapeutics. 2014. PMID: 25015323 Free PMC article. Review.
[Platelets and migraine].
Ollat H, Gurruchaga JM. Ollat H, et al. Among authors: gurruchaga jm. Pathol Biol (Paris). 1992 Apr;40(4):305-12. Pathol Biol (Paris). 1992. PMID: 1495814 Review. French.
Severe Obsessive-Compulsive Disorder Secondary to Neurodegeneration With Brain Iron Accumulation: Complete Remission After Subthalamic Nuclei Deep Brain Stimulation.
Senova S, Mallet L, Gurruchaga JM, Rabu C, Derosin M, Yelnik J, Brugieres P, Pelissolo A, Palfi S, Domenech P. Senova S, et al. Among authors: gurruchaga jm. Biol Psychiatry. 2020 Jun 15;87(12):e39-e41. doi: 10.1016/j.biopsych.2019.07.006. Epub 2019 Aug 28. Biol Psychiatry. 2020. PMID: 31472980 No abstract available.
High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study.
Villafane G, Thiriez C, Audureau E, Straczek C, Kerschen P, Cormier-Dequaire F, Van Der Gucht A, Gurruchaga JM, Quéré-Carne M, Evangelista E, Paul M, Defer G, Damier P, Remy P, Itti E, Fénelon G. Villafane G, et al. Among authors: gurruchaga jm. Eur J Neurol. 2018 Jan;25(1):120-127. doi: 10.1111/ene.13474. Epub 2017 Oct 23. Eur J Neurol. 2018. PMID: 28960663 Clinical Trial.
Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease.
Palfi S, Gurruchaga JM, Lepetit H, Howard K, Ralph GS, Mason S, Gouello G, Domenech P, Buttery PC, Hantraye P, Tuckwell NJ, Barker RA, Mitrophanous KA. Palfi S, et al. Among authors: gurruchaga jm. Hum Gene Ther Clin Dev. 2018 Sep;29(3):148-155. doi: 10.1089/humc.2018.081. Hum Gene Ther Clin Dev. 2018. PMID: 30156440 Free PMC article. Clinical Trial.
21 results